Literature DB >> 11222059

Glucose treatment reduces memory deficits in young adult rats fed high-fat diets.

C E Greenwood1, G Winocur.   

Abstract

Feeding rats high-fat diets for 3 months produces a widespread cognitive deficit that affects performance on a wide range of learning and memory tasks. The present study tested the hypothesis that this effect is related to a fat-induced impairment in glucose metabolism. Following 3 months of dietary intervention (20% by weight fat diets, composed primarily of either beef tallow or soybean oil versus standard laboratory chow), male Long-Evans rats were tested on a variable interval delayed alternation (VIDA) task that measures learning and memory functions that differentially involve specific brain regions. Relative to rats fed chow, rats consuming the high-fat diets were impaired on all aspects of VIDA performance. Following baseline testing, rats were maintained on their respective diets and the effect of glucose administration (100 mg/kg BW; i.p.) was examined. For the next 6 days, animals alternately received injections of saline or glucose 30 min prior to VIDA testing. Glucose treatment improved performance, with the effect being most pronounced at the longer intertrial intervals where task performance is sensitive to hippocampal impairment. Importantly, the beneficial effect of glucose were confined to those animals consuming the high-fat diets and were not observed in rats fed chow. These results demonstrate that glucose administration can overcome those deficits associated with hippocampal function in rats fed high-fat diets and are consistent with the hypothesis that high-fat diets, in part, mediate their effect through the development of insulin resistance and glucose intolerance. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222059     DOI: 10.1006/nlme.2000.3964

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  29 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Bidirectional metabolic regulation of neurocognitive function.

Authors:  Alexis M Stranahan; Mark P Mattson
Journal:  Neurobiol Learn Mem       Date:  2011-01-12       Impact factor: 2.877

Review 3.  Brain insulin: regulation, mechanisms of action and functions.

Authors:  Kyriaki Gerozissis; Gerozissis Kyriaki
Journal:  Cell Mol Neurobiol       Date:  2003-02       Impact factor: 5.046

4.  A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin.

Authors:  A D McNeilly; R Williamson; D J K Balfour; C A Stewart; C Sutherland
Journal:  Diabetologia       Date:  2012-08-18       Impact factor: 10.122

Review 5.  The As and Ds of stress: metabolic, morphological and behavioral consequences.

Authors:  Lawrence P Reagan; Claudia A Grillo; Gerado G Piroli
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

6.  Potential of ezetimibe in memory deficits associated with dementia of Alzheimer's type in mice.

Authors:  Yogita Dalla; Nirmal Singh; Amteshwar Singh Jaggi; Dhandeep Singh; Pooja Ghulati
Journal:  Indian J Pharmacol       Date:  2009-12       Impact factor: 1.200

7.  Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits.

Authors:  Celine Ullrich; Michael Pirchl; Christian Humpel
Journal:  Mol Cell Neurosci       Date:  2010-08-06       Impact factor: 4.314

Review 8.  Damaging effects of a high-fat diet to the brain and cognition: a review of proposed mechanisms.

Authors:  Linnea R Freeman; Vivian Haley-Zitlin; Dorothea S Rosenberger; Ann-Charlotte Granholm
Journal:  Nutr Neurosci       Date:  2013-11-26       Impact factor: 4.994

Review 9.  Insulin signaling effects on memory and mood.

Authors:  Lawrence P Reagan
Journal:  Curr Opin Pharmacol       Date:  2007-11-26       Impact factor: 5.547

Review 10.  Insulin, insulin-like growth factors and incretins: neural homeostatic regulators and treatment opportunities.

Authors:  Roger S McIntyre; Dragana Vagic; Shari A Swartz; Joanna K Soczynska; Hanna O Woldeyohannes; Lakshmi P Voruganti; Jakub Z Konarski
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.